🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Migraine is a neurological disease characterized by moderate or severe head...
Status
Completed
Location
Montefiore/Albert Einstein /ID# 252243
Start Date
2022-12-18
Trial ID
NCT05653986
This study will evaluate the long-term safety, efficacy and tolerability of...
Status
Completed
Location
Takanoko Hospital /ID# 232723
Start Date
2020-06-18
Trial ID
NCT04437433
Treatments Being Tested
A migraine is a moderate to severe headache on one side of the head. A migr...
Status
Completed
Location
Tokyo Dental College Ichikawa General Hospital /ID# 247436
Start Date
2023-07-12
Trial ID
NCT05861427
Treatments Being Tested
The goal of this observational study is to evaluate clinical differences in...
Status
Recruiting
Location
University of Miami, Miller School of Medicine
Start Date
2024-01-02
Trial ID
NCT07159750
Treatments Being Tested
Migraine is a neurological disease characterized by moderate or severe head...
Status
Completed
Location
Edith Wolfson Medical Center /ID# 269740
Start Date
2023-06-25
Trial ID
NCT05827887
Migraine is characterized by attacks of throbbing, moderate or severe heada...
Status
Completed
Location
Chinese PLA General Hospital /ID# 227546
Start Date
2021-08-02
Trial ID
NCT04829747
Treatments Being Tested
Many people with migraine also experience tinnitus - a persistent ringing, ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07
Trial ID
NCT07655440
This study will evaluate safety and tolerability of treatment with atogepan...
Status
Completed
Location
Clinical Research Advantage, Inc./Simon Williamson Clinic, PC
Start Date
2018-10-08
Trial ID
NCT03700320
Treatments Being Tested
This study will evaluate the Long-Term Safety and Tolerability of Atogepant...
Status
Completed
Location
Duplicate_Barrow Neurological Institute /ID# 228217
Start Date
2021-02-19
Trial ID
NCT04686136
Treatments Being Tested
Approved by the Food and Drug Administration (FDA) and the European Medicin...
Status
Recruiting
Location
Istituto Auxologico Italiano IRCCS
Start Date
2022-03-24
Trial ID
NCT07103694
Treatments Being Tested